We are live on ! Find out more
HCC

Hirtle Callaghan & Co Portfolio holdings

AUM $2.92B
1-Year Est. Return 17.65%
This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+17.65%
3 Year Est. Return
+46.66%
5 Year Est. Return
+38.61%
10 Year Est. Return
+120.72%
AUM
$619M
AUM Growth
+$611M
Cap. Flow
+$607M
Cap. Flow %
98.01%
Top 10 Hldgs %
54.74%
Holding
713
New
622
Increased
43
Reduced
2
Closed
4

Top Sells

Rank Stock Value
1
CYH icon
Community Health Systems
CYH
+$110K
2
HSTM icon
HealthStream
HSTM
+$16.3K
3
PCAR icon
PACCAR
PCAR
+$12.5K

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.38%
2 Financials 7.1%
3 Energy 6.16%
4 Healthcare 4.27%
5 Technology 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
376
Amazon
AMZN
$2.5T
$16K ﹤0.01%
+1,000
New +$14.9K
CAH icon
377
Cardinal Health
CAH
$53.4B
$16K ﹤0.01%
+312
New +$15.8K
IXJ icon
378
iShares Global Healthcare ETF
IXJ
$4.11B
$16K ﹤0.01%
+400
New +$15.7K
V icon
379
Visa
V
$677B
$15K ﹤0.01%
+320
New +$14.8K
ARH.PRC.CL
380
DELISTED
Arch Capital Group Ltd
ARH.PRC.CL
$15K ﹤0.01%
+600
New +$14.8K
FBIO icon
381
Fortress Biotech
FBIO
$111M
$14K ﹤0.01%
138
TGNA
382
DELISTED
TEGNA Inc
TGNA
$14K ﹤0.01%
+1,000
New +$13.4K
VYM icon
383
Vanguard High Dividend Yield ETF
VYM
$81.1B
$14K ﹤0.01%
+250
New +$14.5K
BSMX
384
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$14K ﹤0.01%
+1,000
New +$14.3K
TWX
385
DELISTED
Time Warner Inc
TWX
$14K ﹤0.01%
+228
New +$13.6K
POT
386
DELISTED
Potash Corp Of Saskatchewan
POT
$14K ﹤0.01%
+460
New +$15.2K
NWLIA
387
DELISTED
NATL WESTN LIFE INS CO CL A
NWLIA
$14K ﹤0.01%
+67
New +$14K
BG icon
388
Bunge Global
BG
$23.6B
$13K ﹤0.01%
+175
New +$13.3K
GDX icon
389
VanEck Gold Miners ETF
GDX
$23B
$13K ﹤0.01%
+500
New +$13.3K
TS icon
390
Tenaris
TS
$29.1B
$13K ﹤0.01%
+285
New +$12.9K
GM.PRB
391
DELISTED
GENERAL MTRS CO JR PFD CONV SER B (DE)
GM.PRB
$13K ﹤0.01%
+250
New +$12.5K
ARCO icon
392
Arcos Dorados Holdings
ARCO
$1.73B
$12K ﹤0.01%
+1,028
New +$11.8K
RGA icon
393
Reinsurance Group of America
RGA
$15.7B
$12K ﹤0.01%
+180
New +$12.1K
SBS icon
394
Sabesp
SBS
$19.7B
$12K ﹤0.01%
+6,188
New +$11.6K
DFS
395
DELISTED
Discover Financial Services
DFS
$11K ﹤0.01%
+217
New +$10.9K
ELV icon
396
Elevance Health
ELV
$81.9B
$11K ﹤0.01%
+129
New +$11.1K
CHLN
397
DELISTED
CHINA HSG & LD DEV IN COM NEW
CHLN
$11K ﹤0.01%
1,000
IYG icon
398
iShares US Financial Services ETF
IYG
$2.13B
$10K ﹤0.01%
+420
New +$10.5K
SLM icon
399
SLM Corp
SLM
$4.58B
$10K ﹤0.01%
+1,119
New +$9.77K
XLY icon
400
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.4B
$10K ﹤0.01%
+320
New +$9.49K

Similar funds

Hirtle Callaghan & Co's Q3 2013 Portfolio in Review

As of Q3 2013, Hirtle Callaghan & Co held 713 positions worth $619M, up 7,069% from $8.64M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Hirtle Callaghan & Co deployed $607M of net new capital in Q3 2013, opening 622 new positions and adding to 43 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 2,188,869 shares worth $89.2M.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, up from 17% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was HealthStream, an estimated $16.3K trimmed.

  • Hirtle Callaghan & Co's largest Q3 2013 buy was iShares MSCI Emerging Markets ETF: 2,188,869 shares worth $89.2M.
  • Hirtle Callaghan & Co added most to Philip Morris in Q3 2013, an estimated $77.6M increase.
  • Hirtle Callaghan & Co's biggest Q3 2013 reduction was HealthStream, cutting an estimated $16.3K.
  • Hirtle Callaghan & Co fully exited Community Health Systems in Q3 2013, selling an estimated $110K.
  • Hirtle Callaghan & Co's ten largest holdings make up 55% of its $619M portfolio in Q3 2013.
  • Hirtle Callaghan & Co opened 622 new positions and closed 4 in Q3 2013.
  • Hirtle Callaghan & Co's portfolio value rose 7,069% quarter-over-quarter to $619M.

Based on Hirtle Callaghan & Co's 13F filing for Q3 2013, filed 12 Nov 2013.